By Jeffrey Shuren, M.D., J.D. and Thomas P. Gross, M.D., MPH
Blog
TE Connectivity to Acquire AdvancedCath
SCHAFFHAUSEN, Switzerland – February 18, 2015 – TE Connectivity Ltd. (NYSE: TEL), a world leader in connectivity, announced today that it has entered into a definitive agreement to acquire AdvancedCath for $190 million USD in cash.
AdvancedCath is a leading source of advanced catheter systems, with estimated 2015 revenues of $60 million. The company combines best-in-class technologies with industry-leading expertise in lifesaving therapy areas.
The acquisition complements and significantly expands TE’s connectivity and sensor position in the attractive, high-growth interventional space of the medical market. Further, it will allow TE to provide more complete integrated solutions to customers.
Induced pluripotent stem cells: Choosing a reprogramming method
Recent progress on demographic information and clinical trials
By Barbara D. Buch, M.D.
At FDA, one of our foremost responsibilities is to evaluate and if medical products meets the appropriate standard, to approve or clear drugs, biological products and medical devices. We know that these products are safer and more effective for everyone when they are tested in clinical trials that include diverse populations.
A link between cystic fibrosis and arsenic poisoning?
Sirtex Medical Inc. Half-year Dose Sales Surge 28 Percent in Advance of SIRFLOX Primary Endpoint Announcement
WOBURN, Mass. (February 18, 2015) –Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), has announced that dose sales of SIR-Spheres(R) Y-90 resin microspheres in the Americas region grew more than 28 percent for the first half of the company’s fiscal year compared to the same period last year, with 3,390 doses supplied for the period July through December 2014. The gross sales in the region equate to $54.3M in the first half of the current fiscal year compared to $39.8M from the prior year, a 36.7% increase. Globally the company announced sales of 4,950 doses, an increase of 26.3% over the previous corresponding six-month period.
The Precision Medicine Initiative: A child-centered perspective
A child is sick, showing symptoms her parents cannot identify. Something is seriously wrong, but what? The family turns to Boston Children’s Hospital for answers. Yet, even with today’s medical advances, a precise diagnosis often remains elusive.
The meaning of wearing red
A year of significant progress in public health
By Margaret A. Hamburg, M.D.
A new year offers both an opportunity to look forward and an opportunity to reflect on the achievements of the previous year. And, in 2014, FDA’s accomplishments were substantial, touching on many of the agency’s broad responsibilities to protect and promote the public health.
How does a techno-phobic nurse become a hacking aficionado?
By Vector Staff
From a series on researchers and innovators at Boston Children’s Hospital
Margaret McCabe, PhD, director for nursing research in the medicine patient services at Boston Children’s Hospital, is an unlikely hacker. A former techno-phobe and chronically fatigued mother of four, McCabe didn’t think she had time for another project.
Listening to patients’ views on new treatments for obesity
Kathryn O’Callaghan, Associate Director for Science and Strategic Partnerships (Acting), FDA’s Center for Devices and Radiological Health
By Kathryn O’Callaghan and Jeffrey Shuren, M.D., J.D.
The world was a very different place in 1976, when the Food and Drug Administration launched its medical device program.